Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia.
Ma J, Ning YN, Xu M, Hou Y, Wang N, Hou XY, Yu YY, Li H, He WD, Shao LL, Zhou H, Min YN, Liu XG, Shi Y, Qin P, Guo CS, Hou M, Peng J.
Ma J, et al.
Blood. 2013 Sep 19;122(12):2074-82. doi: 10.1182/blood-2013-03-491555. Epub 2013 Aug 7.
Blood. 2013.
PMID: 23926306
Free article.